Medscape is available in 5 Language Editions – Choose your Edition here.


Angiodysplasia of the Colon Treatment & Management

  • Author: Hussein Al-Hamid, MD; Chief Editor: BS Anand, MD  more...
Updated: Jul 27, 2016

Medical Care

Medically manage each patient with angiodysplasia in accordance with the severity of bleeding, hemodynamic stability, and recurrence of symptoms. A conservative approach to patients who are hemodynamically stable is recommended, because most bleeding angiodysplasias will cease spontaneously. Treatment is usually not advocated for asymptomatic patients when angiodysplasias are found incidentally.

Initially, hemodynamically stabilize all patients with active bleeding with intravenous fluids and packed red blood cells as needed. In addition, correct coagulopathies.

Admit the patient with colonic angiodysplasia to the intensive care unit (ICU) if the patient is hemodynamically unstable. Monitor for recurrent bleeding and stabilization of the hematocrit. Transfuse as needed.

When intervention is warranted, institute steps to control hemorrhage. Endoscopic techniques have been employed most frequently.

Gastric and duodenal angiodysplastic lesions have been managed most commonly with endoscopic obliteration techniques. Rebleeding after these techniques has been attributed to other areas of bleeding angiodysplasia rather than failure of obliteration. These techniques include monopolar electrocautery, heater probe, sclerotherapy, band ligation, and argon and neodymium:yttrium-aluminum-garnet (Nd:YAG) lasers.

Monopolar electrocautery has been used to obliterate angiodysplasia; however, bleeding recurs in approximately 50% of subjects. A reduction in the posttherapy transfusion requirement was not reported to be statistically superior to no therapy. Heater probe or multipolar coagulation devices have more favorable results. Monopolar electrocautery has a higher risk of perforation.

Sclerotherapy using 0.5-1 mL of 1.5% sodium tetradecyl sulfate has been used to obliterate upper tract angiodysplastic lesions; however, bleeding recurs in half of the subjects. In each case, bleeding arose from another area of angiodysplasia. A significant rate of complications has been reported with sclerotherapy, including perforation, embolism, bacteremia, and stricture. The authors do not recommend the use of sclerotherapy for obliteration of colonic angiodysplasia.

Argon plasma coagulation (APC) and Nd:YAG lasers are the most successful endoscopic obliterative techniques for upper tract lesions. APC is a no-touch electrocoagulation technique in which high-frequency alternating current is delivered to the tissue through ionized argon gas. A reduction in both the bleeding rate and transfusion requirement has been demonstrated for at least 12 months after laser therapy. However, active bleeding decreases the ablative efficacy of APC by dissipation of the energy, and APC has been associated with colonic perforation.

GI angiodysplasia (GIAD) may be either asymptomatic, or may induce overt or obscure bleeding with a high risk of recurrence. Endoscopic destruction, preferably using noncontact endoscopic techniques, is most often proposed as a first-line treatment for GIAD. In addition, APC is preferred over Nd:Yag laser due to the lower risk of perforation. Octreotide and estroprogestative treatments are the best evaluated drugs; however, no appropriate comparison on cost-effectiveness and tolerance has been performed.[76]

Submucosal injection of a saline epinephrine solution followed by the application of APC has been reported.[77] Effectiveness appeared to be reduced in patients with more numerous lesions, those with coagulation disorders, and those who are older. Rebleeding commonly occurred over time.[77]

New endoscopic techniques such as the Olympus EVIS LUCERA variable indices of hemoglobin chart function have been developed to assess completeness of vascular mucosal ablation.[78] However, their clinical use is still experimental. Argon plasma coagulation appears the best endoscopic option at the moment to control bleeding in these patients with a low rate of adverse effects and complications and relatively lower costs.

Fifty percent of patients with distal small bowel lesions and no other defined GI bleeding sites have benefited from enteroscopy and lesion obliteration. In one report, blood replacement requirements for a group of 13 patients decreased by more than 50%, comparing the years before and after endoscopic treatment, and 31% required no further transfusion.[79] This group of patients had small bowel angiodysplastic lesions and unexplained bleeding. New endoscopic techniques to examine the small bowel, such as double-balloon enteroscopy, have been developed but are time intensive and operator dependent.

Angiodysplasia of colonic origin has been managed by endoscopic obliteration. Heater probe and multipolar electrocoagulation probe have been more successful than monopolar electrocoagulation. Rebleeding rates for monopolar electrocoagulation are approximately 50%, with the transfusion requirement resembling that of patients receiving no therapy.

Super selective embolization of visceral arterial branches is central to the management of patients with lower GI bleeding, including bleeding from colonic angiodysplasia.[80] Immediate cessation of bleeding was achieved in 97% of patients with injection of microcoils, polyvinyl alcohol particles, gel form, or by selective vasopressin infusion. Postembolization ischemia occurs in 3%, and overall mortality in high-risk patients is 9%.[80, 81] Selective infusion of vasopressin is less effective than embolization as a definitive therapy because of high rebleeding rates associated with its use. Despite the fact that intra-arterial vasopressin can achieve hemostasis for massive lower GI bleeding in 70-91% of patients, bleeding recurs after discontinuation of vasopressin in 22-71% of patients.

Endoscopic laser photocoagulation has been successful in controlling bleeding from colonic angiodysplasia, especially right-sided lesions.[77, 82] However, complications occur in as many as 15% of patients and are more common when the Nd:YAG laser is used in the right colon. Complications may be attributed to the deeper coagulation of the vascular abnormalities from laser sources, which incidentally has been responsible for more effective bleeding cessation. Patients with colonic angiodysplasia generally have a 60% chance of remaining free of bleeding at 24 months after laser obliteration.

Emergency embolization with a liquid polyvinyl alcohol copolymer in acute arterial bleeding of the GI tract may be clinically useful.

Endoclips have been used in anecdotal case reports for bleeding angiodysplasia of the cecum and right colon.[80]

Angiodysplasia that presents with acute hemorrhage can be controlled effectively with angiography, although it is seldom needed. Angiography is appropriate in severely ill patients who are not candidates for surgical intervention. In these patients, transcatheter embolization of selected mesenteric arteries has been quite effective. However, the rate of complications is sufficiently high and must be balanced against the risk of surgical resection.

Angiography plays a more important role in the preoperative localization of small bowel lesions immediately before surgical resection, because intraoperative palpation, endoscopy, and visual inspection through multiple enterotomies are of little value with angiodysplasia.

Injection of dyes, such as methylene blue, indigo carmine, and fluorescein, has been used to assist in localization of angiodysplasia before surgical resection.

Patients with systemic sclerosis with severe GAVE refractory to laser ablation may show clinical and endoscopic improvement following intravenous (IV) pulse cyclophosphamide (CYC) treatment.[83] APC is an effective and safe endoscopic treatment for GAVE in patients with liver cirrhosis.[84]

Traditionally, gastroenterologists prefer to use endoscopic modalities like argon plasma coagulation and electrocoagulation to treat accessible vascular lesions. Prospective studies involving 10 or more patients were included in one analysis that showed a clinical response to treatment of 0.76 (95% CI, 0.64-0.85). The weighted mean difference in transfusion requirements before starting therapy (control group) and after treatment initiation (treatment group) was -2.2 (95% CI, -3.9 to -0.5).[85]

Recurrence of acute hemorrhage from GI angiodysplasia after hospital discharge occurred in 30% of patients after a mean follow-up of 33 (±40) months. In a multivariate analysis, earlier history of bleeding with a high bleeding rate, over anticoagulation, and the presence of multiple lesions were predictive factors of recurrence. Surprisingly endoscopic APC therapy was not associated with lower rates of recurrent bleeding.[86]

Different types of gastric vascular ectasia include focal vascular ectasia, portal hypertensive gastropathy, and GAVE. Endoscopic thermal ablation with APC is effective in managing upper GI bleeding.[87]

Endoscopic treatment by APC was successful in about 80% of patients with bleeding gastric vascular ectasia with or without cirrhosis. Noncirrhotic patients required significantly more APC sessions to achieve complete treatment.[88]

Treatment of GAVE, characterized by mucosal and submucosal vascular ectasia causing recurrent GI hemorrhage, with endoscopic thermal therapy (ETT) requires multiple sessions for destruction of vascular ectasia and control of bleeding. Compared with ETT, EBL has a significantly higher rate of bleeding cessation (67% vs 23%, P = .04), fewer treatment sessions required for cessation of bleeding (1.9 vs 4.7, P = .05), a greater increase in hemoglobin values (2.8 g/dL vs 0.9 g/dL, P = .05), a greater decrease in transfusion requirements (-12.7 vs -5.2, P = .02), and a greater decrease in hospital admissions (-2.6 vs -0.5, P = .02) during the follow-up period.[89]

The role of somatostatin analogues for refractory bleeding GI angiodysplasias has been systematically reviewed by Brown et al.[90]

Treatment with continuous octreotide LAR 20mg once a month, reduces transfusion requirements in persons with diffuse small bowel angiodysplasia.[91]

The use of short-acting SMS analogues is recognized in acute variceal hemorrhage secondary to portal hypertension in cirrhosis. Long-acting SMS analogue therapy has been successfully used in obscure GI bleeding thought to be secondary to angiodysplasia.[92]

Rarely, thalidomide may be used in persons with GI angiodysplasia, which has shown no response to standard treatment.[93]

Thalidomide should be considered as a therapeutic option in patients who are resistant to conventional therapy for chronic angiodysplasia bleeding requiring ongoing transfusions. It has a high discontinuation rate because of its side-effects.[94] Thalidomide, with its antiangiogenic mechanism of action, is a promising drug in bleeding angiodysplasias as a treatment option for patients unable to benefit from other available modalities of treatment.[95]


No preventive methods for angiodysplasia have been definitely identified at this time. Avoidance of nonsteroidal anti-inflammatory drugs (NSAIDs) is recommended in patients with chronic bleeding.

Diet and activity

Withhold oral intake until the diagnosis has been made and treatment has been initiated.

Restrict activity until hemodynamic stability can be maintained.


No preventive methods for angiodysplasia have been definitely identified at this time. Avoidance of nonsteroidal anti-inflammatory drugs (NSAIDs) is recommended in patients with chronic bleeding.


Surgical Care

Surgical resection is the definitive treatment for angiodysplasia.

Partial or complete gastrectomy for the management of gastric angiodysplasia has been reported to be followed by bleeding in as many as 50% of patients. Rebleeding was attributed to other angiodysplastic lesions.

Right hemicolectomy for angiodysplasia is a second-line therapy after endoscopic ablation, if repeated endoscopic coagulation has failed, if endoscopic therapies are not available, and for life-threatening hemorrhage.

The mortality rate associated with surgical resection ranges from 10% to 50%. This is based on the view that surgery carries a much higher risk in elderly patients, who often have multiple coexisting medical problems, including coronary artery disease, coagulopathy, and renal and pulmonary dysfunction.

In a study by Meyer et al, right hemicolectomy resulted in 63% of the subjects remaining free of intestinal bleeding (mean follow-up, 3.6 y), and 37% had some degree of recurrent bleeding.[96]

Trends toward reduced transfusion requirements have been observed after surgical resection, as well as after electrocoagulation as the only mode of therapy, and in patients who received no specific intervention.

Surgical resection is preferred for the acute management of severe hemorrhage or for the management of recurrent hemorrhage over a relatively short period accompanied by a large transfusion requirement.


Long-Term Monitoring

The exact time frame for follow-up colonoscopy in patients with angiodysplasia is controversial. If the patient is asymptomatic, a repeat colonoscopy is not recommended. Outpatient monitoring of hemoglobin and repeated tests for occult blood can be performed. Patients with chronic GI bleeding may need repeated colonoscopies.

Contributor Information and Disclosures

Hussein Al-Hamid, MD Fellow, Department of Gastroenterology, Providence Hospital

Hussein Al-Hamid, MD is a member of the following medical societies: American College of Physicians

Disclosure: Nothing to disclose.


Roberto M Gamarra, MD Consulting Gastroenterologist, Digestive Health Associates, PLC

Roberto M Gamarra, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, Crohn's and Colitis Foundation of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Marc D Basson, MD, PhD, MBA, FACS Associate Dean for Medicine, Professor of Surgery and Basic Science, University of North Dakota School of Medicine and Health Sciences

Marc D Basson, MD, PhD, MBA, FACS is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Gastroenterological Association, Phi Beta Kappa, Sigma Xi

Disclosure: Nothing to disclose.

Chief Editor

BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine

BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Additional Contributors

Marco G Patti, MD Professor of Surgery, Director, Center for Esophageal Diseases, University of Chicago Pritzker School of Medicine

Marco G Patti, MD is a member of the following medical societies: American Association for the Advancement of Science, American Surgical Association, American College of Surgeons, American Gastroenterological Association, American Medical Association, Association for Academic Surgery, Pan-Pacific Surgical Association, Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons, Southwestern Surgical Congress, Western Surgical Association

Disclosure: Nothing to disclose.

John Godino, MD Staff Physician, Department of Medicine, Brooke Army Medical Center

John Godino, MD is a member of the following medical societies: American College of Physicians, American Medical Association

Disclosure: Nothing to disclose.

Andrea Duchini, MD Associate Professor of Medicine and Surgery, Director of Hepatology, University of Texas Medical Branch School of Medicine; Medical Director of Liver Transplantation, Department of Surgery, University of Texas Medical Branch School of Medicine

Andrea Duchini, MD is a member of the following medical societies: American College of Physicians, International Liver Transplantation Society, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.


Alan BR Thomson, MD Professor of Medicine, Division of Gastroenterology, University of Alberta, Canada

Alan BR Thomson, MD is a member of the following medical societies: Alberta Medical Association, American College of Gastroenterology, American Gastroenterological Association, Canadian Association of Gastroenterology, Canadian Medical Association, College of Physicians and Surgeons of Alberta, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Peter Wong, MD, Director of Gastroenterology Clinical Service/Manometry and Physiology, Brooke Army Medical Center; Assistant Professor, Department of Medicine, Division of Gastroenterology, University of Texas Health Science Center at San Antonio

Disclosure: Nothing to disclose.

  1. Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2008. 22(2):313-28. [Medline].

  2. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958. 259:196.

  3. Margulis AR, Heinbecker P, Bernard HR. Operative mesenteric arteriography in the search for the site of bleeding in unexplained gastrointestinal hemorrhage: a preliminary report. Surgery. 1960 Sep. 48:534-9. [Medline].

  4. Akhtar AJ, Shaheen MA, Zha J. Organic colonic lesions in patients with irritable bowel syndrome (IBS). Med Sci Monit. 2006 Sep. 12(9):CR363-7. [Medline].

  5. Kim BK, Han HS, Lee SY, Kim CH, Jin CJ. Cecal polypoid arteriovenous malformations removed by endoscopic biopsy. J Korean Med Sci. 2009 Apr. 24(2):342-5. [Medline]. [Full Text].

  6. Clouse RE. Vascular lesions: ectasias, tumors, and malformations. Yamada T, Alpers DH, Laine L, Owyang C, Powell DW, eds. Textbook of Gastroenterology. 3rd ed. Philadelphia, Pa: JB Lippincott; 1999. Vol 2: 2564-78.

  7. Ming SC, Goldman H. Vascular abnormalities of the gastrointestinal tract. Ming SC, Goldman H, eds. Pathology of the Gastrointestinal Tract. 2nd ed. Baltimore, Md: Williams & Wilkins Company; 1998. 272-4.

  8. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol. 1999 Apr. 94(4):1070-6. [Medline].

  9. Mudhar HS, Balsitis M. Colonic angiodysplasia and true diverticula: is there an association?. Histopathology. 2005 Jan. 46(1):81-8. [Medline].

  10. Biss T, Hamilton P. Myelofibrosis and angiodysplasia of the colon: another manifestation of portal hypertension and massive splenomegaly?. J Clin Pathol. 2004 Sep. 57(9):999-1000. [Medline]. [Full Text].

  11. Schmidmaier R, Bittmann I, Gotzberger M, et al. Vascular ectasia of the whole intestine as a cause of recurrent gastrointestinal bleeding after high-dose chemotherapy. Endoscopy. 2006 Sep. 38(9):940-2. [Medline].

  12. Kaaroud H, Fatma LB, Beji S, et al. Gastrointestinal angiodysplasia in chronic renal failure. Saudi J Kidney Dis Transpl. 2008 Sep. 19(5):809-12. [Medline].

  13. Schwartz J, Rozenfeld V, Habot B. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history. Angiology. 1992 Mar. 43(3 pt 1):244-8. [Medline].

  14. Pate GE, Chandavimol M, Naiman SC, Webb JG. Heyde's syndrome: a review. J Heart Valve Dis. 2004 Sep. 13(5):701-12. [Medline].

  15. Ueno S, Nakase H, Kasahara K, et al. Clinical features of Japanese patients with colonic angiodysplasia. J Gastroenterol Hepatol. 2008 Aug. 23(8 pt 2):e363-6. [Medline].

  16. Imperiale TF, Ransohoff DF. Aortic stenosis, idiopathic gastrointestinal bleeding, and angiodysplasia: is there an association? A methodologic critique of the literature. Gastroenterology. 1988 Dec. 95(6):1670-6. [Medline].

  17. Kaaroud H, Fatma LB, Beji S, et al. Gastrointestinal angiodysplasia in chronic renal failure. Saudi J Kidney Dis Transpl. 2008 Sep. 19(5):809-12. [Medline]. [Full Text].

  18. Gola W, Lelonek M. Clinical implication of gastrointestinal bleeding in degenerative aortic stenosis: an update. Cardiol J. 2010. 17(4):330-4. [Medline].

  19. Roskell DE, Biddolph SC, Warren BF. Apparent deficiency of mucosal vascular collagen type IV associated with angiodysplasia of the colon. J Clin Pathol. 1998 Jan. 51(1):18-20. [Medline]. [Full Text].

  20. Slaughter MS. Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res. 2010 Dec. 3(6):618-24. [Medline].

  21. Harvey L, Holley CT, John R. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg. 2014 Sep. 3(5):475-9. [Medline].

  22. Mishra PK, Kovac J, de Caestecker J, et al. Intestinal angiodysplasia and aortic valve stenosis: let's not close the book on this association. Eur J Cardiothorac Surg. 2009 Apr. 35(4):628-34. [Medline].

  23. Vaz A, Correia A, Martins B, et al. Heyde syndrome--the link between aortic stenosis and gastrointestinal bleeding. Rev Port Cardiol. 2010 Feb. 29(2):309-14. [Medline].

  24. Massyn MW, Khan SA. Heyde syndrome: a common diagnosis in older patients with severe aortic stenosis. Age Ageing. 2009 May. 38(3):267-70; discussion 251. [Medline].

  25. Lee HE, Sagong C, Yeo KY, et al. A case of hereditary hemorrhagic telangiectasia. Ann Dermatol. 2009 May. 21(2):206-8. [Medline].

  26. Boubaker K, Boubaker S, Ounissi M, et al. [Colic angiodysplasia and chronic haemodialysis. Argon plasma treatment. A case report]. Nephrol Ther. 2010 Jul. 6(4):248-50. [Medline].

  27. Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol. 2010 Mar. 37(3):603-7. [Medline].

  28. Rosenfeld G, Enns R. Argon photocoagulation in the treatment of gastric antral vascular ectasia and radiation proctitis. Can J Gastroenterol. 2009 Dec. 23(12):801-4. [Medline]. [Full Text].

  29. Selinger CP, Ang YS. Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment. Digestion. 2008. 77(2):131-7. [Medline].

  30. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Quintero E, Perez-Aisa MA. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther. 2011 Mar. 33(5):585-91. [Medline].

  31. Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol. 1995 Apr. 90(4):564-7. [Medline].

  32. Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc. 2010 Feb. 71(2):280-6. [Medline].

  33. Porush JG, Faubert PF. Chronic renal failure. Porush JG, Faubert PF, eds. Renal Disease in the Aged. Boston, MA: Little Brown; 1991.

  34. Zuckerman GR, Cornette GL, Clouse RE, Harter HR. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med. 1985 May. 102 (5):588-92. [Medline].

  35. Rosborough TK, Swaim WR. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia. Am J Med. 1978 Jul. 65(1):96-100. [Medline].

  36. Cass AJ, Bliss BP, Bolton RP, Cooper BT. Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease. Br J Surg. 1980 Sep. 67(9):639-41. [Medline].

  37. Duray PH, Marcal JM Jr, LiVolsi VA, et al. Gastrointestinal angiodysplasia: a possible component of von Willebrand's disease. Hum Pathol. 1984 Jun. 15(6):539-44. [Medline].

  38. Gostout CJ, Bowie EJW, Balm R, Fischer PK. Is angiodysplasia associated with von Willebrand's disease?. Gastroenterology. 1990. 98:A172.

  39. Fressinaud E, Meyer D. International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost. 1993 Sep 1. 70(3):546. [Medline].

  40. Makris M. Gastrointestinal bleeding in von Willebrand disease. Thromb Res. 2006. 118 suppl 1:S13-7. [Medline].

  41. Hirri HM, Green PJ, Lindsay J. Von Willebrand's disease and angiodysplasia treated with thalidomide. Haemophilia. 2006 May. 12(3):285-6. [Medline].

  42. Ueno S, Nakase H, Kasahara K, et al. Clinical features of Japanese patients with colonic angiodysplasia. J Gastroenterol Hepatol. 2008 Aug. 23(8 Pt 2):e363-6. [Medline].

  43. Olokoba AB, Obateru OA, Olatoke SA. Angiodysplasia of the colon: a report of two cases and review of literature. Niger J Clin Pract. 2012 Jan-Mar. 15(1):101-3. [Medline].

  44. Yannam GR, Yu DC, Kelly DR, Chen MK, Beierle EA. Angiodysplasia (vascular malformations) of the colon presenting as an acute abdomen. J Pediatr Surg. 2012 Oct. 47(10):e37-40. [Medline].

  45. Richter JM, Hedberg SE, Athanasoulis CA, Schapiro RH. Angiodysplasia. Clinical presentation and colonoscopic diagnosis. Dig Dis Sci. 1984 Jun. 29(6):481-5. [Medline].

  46. Redondo-Cerezo E, Gomez-Ruiz CJ, Sanchez-Manjavacas N, et al. Long-term follow-up of patients with small-bowel angiodysplasia on capsule endoscopy. Determinants of a higher clinical impact and rebleeding rate. Rev Esp Enferm Dig. 2008 Apr. 100(4):202-7. [Medline].

  47. Emanuel RB, Weiser MM, Shenoy SS, Satchidanand SK, Asirwatham J. Arteriovenous malformations as a cause of gastrointestinal bleeding: the importance of triple-vessel angiographic studies in diagnosis and prevention of rebleeding. J Clin Gastroenterol. 1985 Jun. 7(3):237-46. [Medline].

  48. Macdonald J, Porter V, Scott NW, McNamara D. Small bowel lymphangiectasia and angiodysplasia: a positive association; novel clinical marker or shared pathophysiology?. J Clin Gastroenterol. 2010 Oct. 44(9):610-4. [Medline].

  49. Uhm MS, Kim N, Nah JC, et al. Congenital angiodysplasia in a woman presenting with idiopathic jejunal varicosis on angiography. Gut Liver. 2009 Jun. 3(2):122-6. [Medline]. [Full Text].

  50. Kovacs M, Pak P, Pak G, Feheer J, Huttl K. [Multiple angiodysplasias diagnosed by capsule endoscopy] [Hungarian]. Orv Hetil. 2007 Dec 23. 148(51):2435-40. [Medline].

  51. Jarbandhan S, van der Veer WM, Mulder CJ. Double-balloon endoscopy in the diagnosis and treatment of hemorrhage from retrovalvular angiodysplasias. J Gastrointestin Liver Dis. 2008 Sep. 17(3):333-4. [Medline]. [Full Text].

  52. Monkemuller K, Fry LC, Neumann H, Rickes S, Malfertheiner P. [Diagnostic and therapeutic utility of double balloon endoscopy: experience with 225 procedures] [Spanish]. Acta Gastroenterol Latinoam. 2007 Dec. 37(4):216-23. [Medline].

  53. Skibba RM, Hartong WA, Mantz FA, Hinthorn DR, Rhodes JB. Angiodysplasia of the cecum: colonoscopic diagnosis. Gastrointest Endosc. 1976 Feb. 22(3):177-9. [Medline].

  54. Scaglione G, Russo F, Franco MR, et al. Age and video capsule endoscopy in obscure gastrointestinal bleeding: a prospective study on hospitalized patients. Dig Dis Sci. 2011 Apr. 56(4):1188-93. [Medline].

  55. Tan KK, Wong D, Sim R. Superselective embolization for lower gastrointestinal hemorrhage: an institutional review over 7 years. World J Surg. 2008 Dec. 32(12):2707-15. [Medline].

  56. Fry LC, Bellutti M, Neumann H, Malfertheiner P, Monkemuller K. Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment Pharmacol Ther. 2009 Feb 1. 29(3):342-9. [Medline].

  57. Muhammad A, Pitchumoni CS. Evaluation of iron deficiency anemia in older adults: the role of wireless capsule endoscopy. J Clin Gastroenterol. 2009 Aug. 43(7):627-31. [Medline].

  58. Riccioni ME, Urgesi R, Spada C, et al. Unexplained iron deficiency anaemia: Is it worthwhile to perform capsule endoscopy?. Dig Liver Dis. 2010 Aug. 42(8):560-6. [Medline].

  59. Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc. 2010 Feb. 71(2):280-6. [Medline].

  60. Richardson JD, Max MH, Flint LM Jr, et al. Bleeding vascular malformations of the intestine. Surgery. 1978 Sep. 84(3):430-6. [Medline].

  61. ASGE Technology Committee, Wang A, Banerjee S, Barth BA, et al. Wireless capsule endoscopy. Gastrointest Endosc. 2013 Dec. 78(6):805-15. [Medline].

  62. May A, Farber M, Aschmoneit I, et al. Prospective multicenter trial comparing push-and-pull enteroscopy with the single- and double-balloon techniques in patients with small-bowel disorders. Am J Gastroenterol. 2010 Mar. 105(3):575-81. [Medline].

  63. ASGE Standards of Practice Committee, Khashab MA, Pasha SF, Muthusamy VR, et al. The role of deep enteroscopy in the management of small-bowel disorders. Gastrointest Endosc. 2015 Oct. 82(4):600-7. [Medline].

  64. Rahmi G, Samaha E, Vahedi K, et al. Multicenter comparison of double-balloon enteroscopy and spiral enteroscopy. J Gastroenterol Hepatol. 2013 Jun. 28(6):992-8. [Medline].

  65. Khashab MA, Lennon AM, Dunbar KB, et al. A comparative evaluation of single-balloon enteroscopy and spiral enteroscopy for patients with mid-gut disorders. Gastrointest Endosc. 2010 Oct. 72(4):766-72. [Medline].

  66. Godeschalk MF, Mensink PB, van Buuren HR, Kuipers EJ. Primary balloon-assisted enteroscopy in patients with obscure gastrointestinal bleeding: findings and outcome of therapy. J Clin Gastroenterol. 2010 Oct. 44(9):e195-200. [Medline].

  67. Chen LH, Chen WG, Cao HJ, et al. Double-balloon enteroscopy for obscure gastrointestinal bleeding: a single center experience in China. World J Gastroenterol. 2010 Apr 7. 16(13):1655-9. [Medline].

  68. Hegde SR, Iffrig K, Li T, Downey S, Heller SJ, Tokar JL. Double-balloon enteroscopy in the elderly: safety, findings, and diagnostic and therapeutic success. Gastrointest Endosc. 2010 May. 71(6):983-9. [Medline].

  69. Madisch A, Schmolders J, Bruckner S, Aust D, Miehlke S. Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?. Endoscopy. 2008 Sep. 40(9):731-4. [Medline].

  70. Yeh TS, Liu KH, Su MY, et al. Laparoscopically assisted bowel surgery in an era of double-balloon enteroscopy: from inside to outside. Surg Endosc. 2009 Apr. 23(4):739-44. [Medline].

  71. Kamalaporn P, Cho S, Basset N, et al. Double-balloon enteroscopy following capsule endoscopy in the management of obscure gastrointestinal bleeding: outcome of a combined approach. Can J Gastroenterol. 2008 May. 22(5):491-5. [Medline].

  72. Arakawa D, Ohmiya N, Nakamura M, et al. Outcome after enteroscopy for patients with obscure GI bleeding: diagnostic comparison between double-balloon endoscopy and videocapsule endoscopy. Gastrointest Endosc. 2009 Apr. 69(4):866-74. [Medline].

  73. Crook DW, Knuesel PR, Froehlich JM, et al. Comparison of magnetic resonance enterography and video capsule endoscopy in evaluating small bowel disease. Eur J Gastroenterol Hepatol. 2009 Jan. 21(1):54-65. [Medline].

  74. Westerhoff M, Tretiakova M, Hovan L, Miller J, Noffsinger A, Hart J. CD61, CD31, and CD34 improve diagnostic accuracy in gastric antral vascular ectasia and portal hypertensive gastropathy: An immunohistochemical and digital morphometric study. Am J Surg Pathol. 2010 Apr. 34(4):494-501. [Medline].

  75. Pavlov KA, Chekmaryova IA, Shchyogolev AI, Mishnyov OD. Ultrastructural characteristics of peripheral arteriovenous and venous angiodysplasias. Bull Exp Biol Med. 2009 Apr. 147(4):480-4. [Medline].

  76. Dray X, Camus M, Coelho J, et al. Treatment of gastrointestinal angiodysplasia and unmet needs. Dig Liver Dis. 2011 Jul. 43(7):515-22. [Medline].

  77. Suzuki N, Arebi N, Saunders BP. A novel method of treating colonic angiodysplasia. Gastrointest Endosc. 2006 Sep. 64(3):424-7. [Medline].

  78. Hurlstone DP, Karageh M, Sanders DS. The Olympus EVIS LUCERA variable indices of haemoglobin chart function: a novel technique for establishing the completeness of vascular mucosal ablation in colonic angiodysplasia. Endoscopy. 2006 Jan. 38(1):102. [Medline]. [Full Text].

  79. Vakil N, Huilgol V, Khan I. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding. Am J Gastroenterol. 1997 Mar. 92(3):425-8. [Medline].

  80. Pishvaian AC, Lewis JH. Use of endoclips to obliterate a colonic arteriovenous malformation before cauterization. Gastrointest Endosc. 2006 May. 63(6):865-6. [Medline].

  81. Rossetti A, Buchs NC, Breguet R, Bucher P, Terraz S, Morel P. Transarterial embolization in acute colonic bleeding: review of 11 years of experience and long-term results. Int J Colorectal Dis. 2013 Jun. 28(6):777-82. [Medline].

  82. Polese L, Angriman I, Pagano D, et al. Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia. Lasers Med Sci. 2006 Sep. 21(3):140-6. [Medline].

  83. Schulz SW, O'Brien M, Maqsood M, et al. Improvement of severe systemic sclerosis-associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. J Rheumatol. 2009 Aug. 36(8):1653-6. [Medline].

  84. Fuccio L, Zagari RM, Serrani M, et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion. 2009. 79(3):143-50. [Medline].

  85. Brown C, Subramanian V, Wilcox CM, Peter S. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies. Dig Dis Sci. 2010 Aug. 55(8):2129-34. [Medline].

  86. Saperas E, Videla S, Dot J, et al. Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia. Eur J Gastroenterol Hepatol. 2009 Dec. 21(12):1333-9. [Medline].

  87. Herrera S, Bordas JM, Llach J, et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc. 2008 Sep. 68(3):440-6. [Medline].

  88. Lecleire S, Ben-Soussan E, Antonietti M, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc. 2008 Feb. 67(2):219-25. [Medline].

  89. Wells CD, Harrison ME, Gurudu SR, et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc. 2008 Aug. 68(2):231-6. [Medline].

  90. Molina Infante J, Perez Gallardo B, Hernandez Alonso M, et al. [Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities]. Med Clin (Barc). 2009 Nov 7. 133(17):667-70. [Medline].

  91. Molina-Infante J, Perez-Gallardo B. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?. Dig Dis Sci. 2011 Jan. 56(1):266-7. [Medline].

  92. Hutchinson JM, Jennings JS, Jones RL. Long-acting somatostatin analogue therapy in obscure-overt gastrointestinal bleeding in noncirrhotic portal hypertension: a case report and literature review. Eur J Gastroenterol Hepatol. 2010 Jun. 22(6):754-8. [Medline].

  93. Belard E, Foss CH, Christensen LA, Schmidt P, Nojgaard C. [Thalidomide therapy for gastrointestinal angiodysplasia]. Ugeskr Laeger. 2009 Nov 16. 171(47):3454-5. [Medline].

  94. Kamalaporn P, Saravanan R, Cirocco M, et al. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series. Eur J Gastroenterol Hepatol. 2009 Dec. 21(12):1347-50. [Medline].

  95. Dabak V, Kuriakose P, Kamboj G, Shurafa M. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dig Dis Sci. 2008 Jun. 53(6):1632-5. [Medline].

  96. Meyer CT, Troncale FJ, Galloway S, Sheahan DG. Arteriovenous malformations of the bowel: an analysis of 22 cases and a review of the literature. Medicine (Baltimore). 1981 Jan. 60(1):36-48. [Medline].

  97. Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis. Am J Gastroenterol. 2014 Apr. 109(4):474-83; quiz 484. [Medline].

  98. Lewis BS, Salomon P, Rivera-MacMurray S, et al. Does hormonal therapy have any benefit for bleeding angiodysplasia?. J Clin Gastroenterol. 1992 Sep. 15(2):99-103. [Medline].

  99. Alavi A, Ring EJ. Localization of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography. AJR Am J Roentgenol. 1981 Oct. 137(4):741-8. [Medline]. [Full Text].

  100. Alvarez L, Puleo J, Balint JA. Investigation of gastrointestinal bleeding in patients with end stage renal disease. Am J Gastroenterol. 1993 Jan. 88(1):30-3. [Medline].

  101. Apostolakis E, Doering C, Kantartzis M, Winter J, Schulte HD. Calcific aortic-valve stenosis and angiodysplasia of the colon: Heyde's syndrome--report of two cases. Thorac Cardiovasc Surg. 1990 Dec. 38(6):374-6. [Medline].

  102. Bhutani MS, Gupta SC, Markert RJ, et al. A prospective controlled evaluation of endoscopic detection of angiodysplasia and its association with aortic valve disease. Gastrointest Endosc. 1995 Nov. 42(5):398-402. [Medline].

  103. Boley SJ, Sammartano R, Adams A, et al. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology. 1977 Apr. 72(4 pt 1):650-60. [Medline].

  104. Boley SJ, Sprayregen S, Sammartano RJ, Adams A, Kleinhaus S. The pathophysiologic basis for the angiographic signs of vascular ectasias of the colon. Radiology. 1977 Dec. 125(3):615-21. [Medline].

  105. Brandt LJ, Mukhopadhyay D. Masking of colon vascular ectasias by cold water lavage. Gastrointest Endosc. 1999 Jan. 49(1):141-2. [Medline].

  106. Britt LG, Warren L, Moore OF 3rd. Selective management of lower gastrointestinal bleeding. Am Surg. 1983 Mar. 49(3):121-5. [Medline].

  107. Browder W, Cerise EJ, Litwin MS. Impact of emergency angiography in massive lower gastrointestinal bleeding. Ann Surg. 1986 Nov. 204(5):530-6. [Medline]. [Full Text].

  108. Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol. 1996 Nov. 91(11):2329-32. [Medline].

  109. Chou CC, Dabney JM. Interrelation of ileal wall compliance and vascular resistance. Am J Dig Dis. 1967 Dec. 12(12):1198-208. [Medline].

  110. Cottone C, Disclafani G, Genova G, et al. Use of BICAP in a case of colon angiodysplasia. Surg Endosc. 1991. 5(2):99-100. [Medline].

  111. Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol. 1998 Sep. 93(9):1453-6. [Medline].

  112. Ettorre GC, Francioso G, Garribba AP, et al. Helical CT angiography in gastrointestinal bleeding of obscure origin. AJR Am J Roentgenol. 1997 Mar. 168(3):727-31. [Medline]. [Full Text].

  113. Flynn CT, Chandran PK. Renal failure and angiodysplasia of the colon. Ann Intern Med. 1985 Jul. 103(1):154. [Medline].

  114. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol. 1993 Jun. 88(6):807-18. [Medline].

  115. Foutch PG. Colonic angiodysplasia. Gastroenterologist. 1997 Jun. 5(2):148-56. [Medline].

  116. Ghosh J, Speake D, Benbow EW, Watson AJ. Co-existence of true colonic diverticula with angiodysplasia. Colorectal Dis. 2005 Sep. 7(5):530-2. [Medline].

  117. Greason KL, Acosta JA, Magrino TJ, Choe M. Angiodysplasia as the cause of massive lower gastrointestinal hemorrhage in a young adult. Report of a case. Dis Colon Rectum. 1996 Jun. 39(6):702-4. [Medline].

  118. Gupta N, Longo WE, Vernava AM 3rd. Angiodysplasia of the lower gastrointestinal tract: an entity readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum. 1995 Sep. 38(9):979-82. [Medline].

  119. Hemingway AP. Angiodysplasia as a cause of iron deficiency anaemia. Blood Rev. 1989 Sep. 3(3):147-51. [Medline].

  120. Ho S, Jackson J. The angiographic diagnosis of colonic carcinoma. Clin Radiol. 1998 May. 53(5):345-9. [Medline].

  121. Hochter W, Weingart J, Kuhner W, Frimberger E, Ottenjann R. Angiodysplasia in the colon and rectum. Endoscopic morphology, localisation and frequency. Endoscopy. 1985 Sep. 17(5):182-5. [Medline].

  122. Howard OM, Buchanan JD, Hunt RH. Angiodysplasia of the colon. Experience of 26 cases. Lancet. 1982 Jul 3. 2(8288):16-9. [Medline].

  123. Katsinelos P, Paroutoglou G, Beltsis A, et al. Recurrent colonic Dieulafoy's lesion associated with bizarre vascular malformations and abnormal von Willebrand factor. Acta Gastroenterol Belg. 2005 Oct-Dec. 68(4):443-5. [Medline].

  124. Kheterpal S. Angiodysplasia: a review. J R Soc Med. 1991 Oct. 84(10):615-8. [Medline]. [Full Text].

  125. Kitiyakara T, Selby W. Non-small-bowel lesions detected by capsule endoscopy in patients with obscure GI bleeding. Gastrointest Endosc. 2005 Aug. 62(2):234-8. [Medline].

  126. Krevsky B. Detection and treatment of angiodysplasia. Gastrointest Endosc Clin N Am. 1997 Jul. 7(3):509-24. [Medline].

  127. Moparty B, Raju GS. Role of hemoclips in a patient with cecal angiodysplasia at high risk of recurrent bleeding from antithrombotic therapy to maintain coronary stent patency: a case report. Gastrointest Endosc. 2005 Sep. 62(3):468-9. [Medline].

  128. Noer RJ, Derr JW. Effect of distention on intestinal revascularization. Arch Surg. 1949 Sep. 59(3):542-9. [Medline].

  129. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis. 2001 May. 33(4):330-4. [Medline].

  130. Potter GD, Sellin JH. Lower gastrointestinal bleeding. Gastroenterol Clin North Am. 1988 Jun. 17(2):341-56. [Medline].

  131. Reinus JF, Brandt LJ. Vascular ectasias and diverticulosis. Common causes of lower intestinal bleeding. Gastroenterol Clin North Am. 1994 Mar. 23(1):1-20. [Medline].

  132. Roberts PL, Schoetz DJ Jr, Coller JA. Vascular ectasia. Diagnosis and treatment by colonoscopy. Am Surg. 1988 Jan. 54(1):56-9. [Medline].

  133. Sabanathan S, Nag SB. Angiodysplasia of the colon: a post-mortem study. J R Coll Surg Edinb. 1982 Sep. 27(5):285-91. [Medline].

  134. Scheffer SM, Leatherman LL. Resolution of Heyde's syndrome of aortic stenosis and gastrointestinal bleeding after aortic valve replacement. Ann Thorac Surg. 1986 Oct. 42(4):477-80. [Medline].

  135. Semba T, Fujii Y. Relationship between venous flow and colonic peristalsis. Jpn J Physiol. 1970 Aug. 20(4):408-16. [Medline].

  136. Serin E, Paydas S, Yildizer K, Seyrek N, Sagliker Y. von Recklinghausen's disease associated with angiodysplasia of colon and end-stage renal disease. Nephron. 1995. 71(2):243. [Medline].

  137. Sharma R, Gorbien MJ. Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients. Arch Intern Med. 1995 Apr 24. 155(8):807-12. [Medline].

  138. Szilagyi A, Ghali MP. Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol. 2006 Mar. 20(3):171-8. [Medline]. [Full Text].

  139. Tedesco FJ, Waye JD, Raskin JB, Morris SJ, Greenwald RA. Colonoscopic evaluation of rectal bleeding: a study of 304 patients. Ann Intern Med. 1978 Dec. 89(6):907-9. [Medline].

  140. Thelmo WL, Vetrano JA, Wibowo A, et al. Angiodysplasia of colon revisited: pathologic demonstration without the use of intravascular injection technique. Hum Pathol. 1992 Jan. 23(1):37-40. [Medline].

  141. Welch CE, Athanasoulis CA, Galdabini JJ. Hemorrhage from the large bowel with special reference to angiodysplasia and diverticular disease. World J Surg. 1978 Jan. 2(1):73-83. [Medline].

  142. Wright HK, Pelliccia O, Higgins EF Jr, Sreenivas V, Gupta A. Controlled, semielective, segmental resection for massive colonic hemorrhage. Am J Surg. 1980 Apr. 139(4):535-8. [Medline].

  143. Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol. 1992 Jan. 87(1):62-6. [Medline].

Algorithm for acute gastrointestinal (GI) bleeding. CBC = complete blood cell count; CXR = chest x-ray; EKG = electrocardiography; IVF = intravenous fluid; NG = nasogastric.
Angiodysplasia identified on the cecum wall during colonoscopy.
Double-contrast barium enema studies in a 44-year-old man known to have a long history of ulcerative colitis. These images show total colitis and extensive pseudopolyposis.
Double-contrast barium enema examination in a patient with Crohn colitis demonstrates numerous aphthous ulcers.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.